While common ophthalmic diseases, such as age-related macular degeneration or cataract or glaucoma, have minimal clinical relevance to other areas of medicine, coronavirus disease 2019 (COVID-19) and ophthalmology have had immediate connections and importance for hospital epidemiology and infection control experts, public health officials, and the general population. In the first preliminary study of characteristics of ocular findings among 38 patients hospitalized with COVID-19 in Hubei province, China, Wu et al1 reported conjunctivitis in 12 (38%). Virus material also was detected on swabs of the conjunctiva among 2 of 11 patients (18%) tested for COVID-19 in this manner.